SHL Telemedicine Ltd. engages in the development and market of advanced personal telemedicine solutions, which focuses on cardiovascular and related diseases. Its products and solutions include congestive heart failure, chronic obstructive pulmonary disease and cardiac monitoring services. It operates through the following geographical segments: Israel, Europe principally Germany, and Rest of the World. The company was founded by Yoram Alroy and Elon Shalev in 1987 and is headquartered in Tel Aviv, Israel.
Sector:
Health Services
Industry:
Medical Or Nursing Services
Employees:
526
Frequently Asked Questions
What is Market Cap of SHL Telemedicine Ltd.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. SHL Telemedicine Ltd. market cap is $20.41M.
How many employess does SHL Telemedicine Ltd. has?